Literature DB >> 23041357

Laboratory methods to study African swine fever virus.

Patricia de León1, María J Bustos, Angel L Carrascosa.   

Abstract

We summarize findings of comparative studies in different cells cultures susceptible to ASFV infection, through the analysis of virus components and infectious virus particles production, as alternative means to grow field and laboratory ASFV strains. We also provide different methods to assay the infectivity of ASFV samples and to purify the infective virus particles. Finally we describe the general strategy to construct virus deletion mutants that can be engineered to obtain attenuated ASFV strains suitable for vaccine approaches.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23041357     DOI: 10.1016/j.virusres.2012.09.013

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  22 in total

1.  Assessment of African Swine Fever Diagnostic Techniques as a Response to the Epidemic Outbreaks in Eastern European Union Countries: How To Improve Surveillance and Control Programs.

Authors:  C Gallardo; R Nieto; A Soler; V Pelayo; J Fernández-Pinero; I Markowska-Daniel; G Pridotkas; I Nurmoja; R Granta; A Simón; C Pérez; E Martín; P Fernández-Pacheco; M Arias
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

Review 2.  Attenuated African swine fever virus through serial passaging of viruses in cell culture: a brief review on the knowledge gathered during 60 years of research.

Authors:  Xiaoyue Zhang; Zhenzhong Wang; Shengqiang Ge; Yuanyuan Zuo; Haodong Lu; Yan Lv; Naijun Han; Yumei Cai; Xiaodong Wu; Zhiliang Wang
Journal:  Virus Genes       Date:  2022-10-14       Impact factor: 2.198

3.  Development of optimized protocol for culturing African swine fever virus field isolates in MA104 cells.

Authors:  Hyeok-Il Kwon; Duy Tien Do; Hung Van Vo; Seung-Chul Lee; Min Ho Kim; Dung Thi Thuy Nguyen; Tan Minh Tran; Quang Tin Vinh Le; Tram Thi Ngoc Ngo; Nam Minh Nguyen; Joo Young Lee; Toan Tat Nguyen
Journal:  Can J Vet Res       Date:  2022-10       Impact factor: 0.897

4.  African Swine Fever Virus Hemadsorption Inhibition Assay.

Authors:  Alexander Malogolovkin; Alexey Sereda
Journal:  Methods Mol Biol       Date:  2022

5.  Isolation of Porcine Bone Marrow Cells and Generation of Recombinant African Swine Fever Viruses.

Authors:  Anusyah Rathakrishnan; Ana Luisa Reis; Katy Moffat; Linda K Dixon
Journal:  Methods Mol Biol       Date:  2022

Review 6.  Cell Lines for the Development of African Swine Fever Virus Vaccine Candidates: An Update.

Authors:  Dionigia Meloni; Giulia Franzoni; Annalisa Oggiano
Journal:  Vaccines (Basel)       Date:  2022-04-29

7.  Phenotyping and susceptibility of established porcine cells lines to African Swine Fever Virus infection and viral production.

Authors:  Elena G Sánchez; Elena Riera; Marisa Nogal; Carmina Gallardo; Paloma Fernández; Raquel Bello-Morales; José Antonio López-Guerrero; Carol G Chitko-McKown; Jürgen A Richt; Yolanda Revilla
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

8.  Attempts at the Development of a Recombinant African Swine Fever Virus Strain with Abrogated EP402R, 9GL, and A238L Gene Structure using the CRISPR/Cas9 System.

Authors:  Grzegorz Woźniakowski; Natalia Mazur-Panasiuk; Marek Walczak; Małgorzata Juszkiewicz; Maciej Frant; Krzysztof Niemczuk
Journal:  J Vet Res       Date:  2020-06-03       Impact factor: 1.744

Review 9.  Approaches and Perspectives for Development of African Swine Fever Virus Vaccines.

Authors:  Marisa Arias; Ana de la Torre; Linda Dixon; Carmina Gallardo; Ferran Jori; Alberto Laddomada; Carlos Martins; R Michael Parkhouse; Yolanda Revilla; Fernando And Jose-Manuel Rodriguez
Journal:  Vaccines (Basel)       Date:  2017-10-07

10.  Production of Recombinant African Swine Fever Viruses: Speeding Up the Process.

Authors:  Anusyah Rathakrishnan; Katy Moffat; Ana Luisa Reis; Linda K Dixon
Journal:  Viruses       Date:  2020-06-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.